Here, we performed exome sequencing on 19 ULMSs to further elucidate the molecular etiology of these tumors, identifying frequent mutations in TP53, alpha thalassemia/mental retardation syndrome X-linked (ATRX), and mediator complex subunit 12 (MED12). The gene discussed is ATRX; the disease is alpha thalassemia spectrum.